LABP News and Press, Landos Biopharma Inc. From 12/19/22

Hot Penny Stocks To Buy For Under $3 Are you looking for penny stocks to buy today? You’re not alone, and the process of finding them isn’t as easy as you might think. One of the main reasons is the much higher volatility in the stock market today. It isn’t just penny s...

Landos Biopharma press release ( NASDAQ: LABP ): Q3 GAAP EPS of -$0.20 beats by $0.08 . As of September 30, 2022, the Company had cash, cash equivalents and marketable securities of $48.0 million, which it believes will be sufficient to fund its planned operations for ...

NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. (NASDAQ: LABP), a clinical-stage biopharmaceutical company developing novel, oral medicines for patients with autoimmune diseases, today announced financial results for the third quarter ended September 30, 2022, and provide...

Landos Biopharma ( NASDAQ: LABP ) has appointed Fabio Cataldi, MD, as the company’s Chief Medical Officer, effective September 5, 2022. Most recently, Dr. Cataldi served as Arena’s Vice President and Therapeutic Area Head Gastroenterology, where he ...

NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. (NASDAQ: LABP), a clinical-stage biopharmaceutical company developing novel, oral medicines for patients with autoimmune diseases, today announced the appointment of Fabio Cataldi, MD, as the Company’s Chief Medical ...

Landos Biopharma press release ( NASDAQ: LABP ): Q2 GAAP EPS of -$0.28. As of June 30, 2022, the company had cash, cash equivalents and marketable securities of $55.8M, which it believes will be sufficient to fund its planned operations for at least the next 12 months. ...

Positive Top-Line Results From NX-13 Phase 1b Trial in Ulcerative Colitis Demonstrate a Favorable Safety and Tolerability Profile Across Range of Once-Daily Oral Doses, as well as Promising Early Efficacy Signals Phase 2 Proof of Concept Clinical Trial for NX-13 in Ulcerative Co...

Pineapple Energy ( PEGY ) +75% . Atlas ( ATCO ) +24% after receives takeover offer from Poseidon. Pagaya Technologies  ( PGY ) +22% . The Joint ( JYNT ) +22% GAAP EPS of $0.02 beats by $0.01, revenue of $25.06M beats by $1.51M. ...

NX-13 Demonstrated Favorable Safety and Tolerability Profile Across Range of Once-Daily Doses Results Indicate Promising Early Signals Regarding the Efficacy of NX-13 Phase 2 Proof of Concept Clinical Trial in Ulcerative Colitis Planned NEW YORK, Aug. 03, 2022 (GLO...

Landos Biopharma (NASDAQ:LABP) +5% on Tuesday has announced the appointment of Gregory Oakes as its president and chief effective officer, effective immediately. Oakes most recently served as president, North America, EVP and member of the executive committee of Vifor...